Hereditary Genetic Panels
Genetic testing provides early detection,
and targeted screening reduces advanced
This might save lives and can help determine if your patient has an increased risk of certain types of cancer. Early detection of cancer can greatly improve the odds of successful treatment and survival.
For inherited cancer syndromes the identification of a pathogenic variant can confirm a genetic diagnosis with great impact on the patients’ health. For a most comprehensive interpretation of the analysis results and phenotype, thorough clinical information is critical. A full medical report including analysis results and their proper interpretation on the basis of the clinical information provides the basis for further tailored diagnostic and therapeutic strategy.
Sayre offers a comprehensive panel that analyzes ~6700 genes across various indications listed below:
- Hereditary Breast and Ovarian, Cancer
- Hereditary Spherocytosis (HS)
- Hemophagocytic Lymphohistiocytosis (HLH)
- Fanconi Anemia
- Severe combined Immunodeficiency (SCID)
- Diamond Black fan anemia disorders
And many other hereditary cancers.
We offer Next Generation Sequencing and Sanger’s validation for the positive mutations of related phenotypes and also provide comprehensive and patient specific interpretation report for all the tests with optional support from geneticists to help interpret results. All tests are performed in an ISO Certified, CLIA registered and CAP accredited laboratory.